These studies suggested that the pretreatment of Forsythiaside could efficiently act on the kidney to keep podocytes functioning normally through targeting RHOA and PRKCA and could be developed as a potential natural antioxidant and therapy for DKD podocyte injury by controlling mTOR signaling pathways. This evidence concerns the gene PRKCA and diabetic kidney disease.